What is Spravato?

SPRAVATO® offers a different approach and is the only
FDA-approved nasal spray treatment for treatment-resistant depression (TRD)

Bee Well Family Healthcare is proud to serve as a SPRAVATO® REMS certified treatment center.

SPRAVATO® Risk Evaluation and Mitigation Strategy (REMS)

Because of the risks for sedation, dissociation, respiratory depression, and abuse and misuse, SPRAVATO® is only available through a restricted program called the SPRAVATO® Risk Evaluation and Mitigation Strategy (REMS) Program. SPRAVATO® can only be administered at healthcare settings certified in the SPRAVATO® REMS Program. Patients treated in outpatient healthcare settings (such as medical offices and clinics) must be enrolled in the program.

Learn More

Is there proof that Spravato can help?

In a short-term study, more patients using SPRAVATO® plus oral antidepressant demonstrated rapid and superior reduction in depressive symptoms at four weeks compared to those who received placebo plus an oral antidepressant*
• Most of the reduction in depressive symptoms was seen at
24 hours
• Between 24 hours and four weeks, both groups continued to
improve; the difference in improvement between the groups
remained but did not appear to increase through four weeks

Click to Learn More